Grant of Options

RNS Number : 0939K

ValiRx PLC

11 July 2011

 



11 July 2011

ValiRx Plc (AIM: VAL)

("ValiRx" or the "Company")

Grant of options

ValiRx, a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that on 8 July 2011 it granted 42,500,000 options over ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") to certain employees and directors of the Company, as set out in the table below.

Name of director	Number of shares held	% of issued share capital	Number of existing options	Number of new options granted	Total options now held	Options held as % of issued share capital
Satu Vainikka	16,644,221	1.59%	1,000,000	10,000,000	11,000,000	1.05%
Nick Thorniley	8,213,035	0.79%	400,000	6,000,000	6,400,000	0.61%
George Morris	11,409,944	1.09%	750,000	6,000,000	6,750,000	0.65%
Gerry Desler	6,154,761	0.59%	400,000	6,000,000	6,400,000	0.61%
Kevin Alexander	2,688,750	0.26%	400,000	6,000,000	6,400,000	0.61%
Oliver de Giorgio-Miller	Nil	Nil	Nil	3,000,000	3,000,000	0.29%
Total Directors	45,110,711	4.32%	2,950,000	37,000,000	39,950,000	3.82%
Other employees	Nil	Nil	600,000	5,500,000	6,100,000	0.59%
Total	45,110,711	4.32%	3,550,000	42,500,000	46,050,000	4.41%

The new options were granted under the Company's stock option plan and have an exercise price of  0.75 pence. The new options are exercisable between 8 July 2011 and 7 July 2021.

Following the grant of the new options, the total number of Ordinary Shares under option held by directors which could be issued is 39,950,000 Ordinary Shares, representing approximately 3.8 per cent. of the current issued share capital of the Company.

In addition, a further 5,500,000 options have been granted to employees of the Company at an exercise price of 0.75 pence which are exercisable until 7 July 2021.

The issued share capital of the Company comprises 1,044,562,609 ordinary shares of 0.1 pence each.

For more information, please contact:

ValiRx plc	www.ValiRx.com
Dr Satu Vainikka	Tel: [phone]
Cairn Financial Advisers LLP
Nominated Adviser	Tel:[phone]
Liam Murray / Avi Robinson
Hybridan LLP
Broker	Tel: [phone]
Claire Noyce
Peckwater PR	Tel: [phone]
Tarquin Edwards	[e-mail]

 

END

 

 

RDSBUGDRLUGBGBI